These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 17430797)

  • 41. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cardiac involvement in systemic autoimmune disease].
    Dropiński J; Szczeklik W; Rubiś P
    Pol Arch Med Wewn; 2003 Apr; 109(4):375-81. PubMed ID: 12931489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

  • 44. T cell subsets and their role in the pathogenesis of rheumatic disease.
    Gizinski AM; Fox DA
    Curr Opin Rheumatol; 2014 Mar; 26(2):204-10. PubMed ID: 24445478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept].
    Breedveld FC
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2273-7. PubMed ID: 16240851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases].
    Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G
    Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047
    [No Abstract]   [Full Text] [Related]  

  • 47. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemokines in rheumatic diseases.
    Szekanecz Z; Szücs G; Szántó S; Koch AE
    Curr Drug Targets; 2006 Jan; 7(1):91-102. PubMed ID: 16454702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inflammatory rheumatism within the framework of autoimmune diseases].
    Van Slype J
    J Belge Rhumatol Med Phys; 1967; 22(4):204-7. PubMed ID: 4185872
    [No Abstract]   [Full Text] [Related]  

  • 50. Rheumatic diseases and Klinefelter's syndrome.
    Rovenský J; Imrich R; Lazúrová I; Payer J
    Ann N Y Acad Sci; 2010 Apr; 1193():1-9. PubMed ID: 20398000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The management of collagen diseases.
    Calin A
    Ration Drug Ther; 1980 Jan; 14(1):1-5. PubMed ID: 7384531
    [No Abstract]   [Full Text] [Related]  

  • 52. The weight of interleukin-6 in B cell-related autoimmune disorders.
    Youinou P; Jamin C
    J Autoimmun; 2009; 32(3-4):206-10. PubMed ID: 19307104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Autoimmune disorders associated with acquired autoimmune myasthenia gravis].
    Nakao N; Sahashi K
    Ryoikibetsu Shokogun Shirizu; 2001; (36):347-50. PubMed ID: 11596406
    [No Abstract]   [Full Text] [Related]  

  • 54. Role of biological agents in immune-mediated inflammatory diseases.
    Efthimiou P; Markenson JA
    South Med J; 2005 Feb; 98(2):192-204. PubMed ID: 15759950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arthritis-associated syndromes.
    Osial TA; Cash JM; Eisenbeis CH
    Prim Care; 1993 Dec; 20(4):857-82. PubMed ID: 8310085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune rheumatic diseases in women.
    Schuna AA
    J Am Pharm Assoc (Wash); 2002; 42(4):612-23; quiz 623-4. PubMed ID: 12150360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunological therapies for rheumatoid arthritis.
    Edwards CJ
    Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study.
    Falasinnu T; Lu D; Baker MC
    Lancet Rheumatol; 2024 Aug; 6(8):e518-e527. PubMed ID: 38945137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Scleroderma and its relationship to the "collagenoses": dermatomyositis, lupus erythematosus, rheumatoid arthritis and Sjogren's syndrome.
    TUFFANELLI DL
    Am J Med Sci; 1962 Feb; 243():133-46. PubMed ID: 13923027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.